West Pharmaceutical Services Company Profile (NYSE:WST)

About West Pharmaceutical Services (NYSE:WST)

West Pharmaceutical Services logoWest Pharmaceutical Services, Inc. is a manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. The Company's products include vial containment solutions, prefillable systems, self-injection platforms, cartridge systems and components, reconstitution and transfer systems, intradermal delivery solutions, specialty components, and contract manufacturing and analytical services. The Company's segments include Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment develops commercial and operational strategies across its global network, with specific emphasis on product offerings to biologic, generic and pharmaceutical drug customers. The Contract-Manufactured Products segment serves as an integrated business focused on the design, manufacture and automated assembly of various devices, primarily for pharmaceutical, diagnostic and medical device customers.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Equipment, Supplies & Distribution
  • Sub-Industry: Health Care Supplies
  • Symbol: NYSE:WST
  • CUSIP: 95530610
  • Web: www.westpharma.com
Capitalization:
  • Market Cap: $7.04573 billion
  • Outstanding Shares: 74,002,000
Average Prices:
  • 50 Day Moving Avg: $87.78
  • 200 Day Moving Avg: $89.57
  • 52 Week Range: $70.17 - $99.91
P/E:
  • Trailing P/E Ratio: 40.86
  • Foreward P/E Ratio: 32.83
  • P/E Growth: 1.94
Sales & Book Value:
  • Annual Revenue: $1.54 billion
  • Price / Sales: 4.58
  • Book Value: $16.79 per share
  • Price / Book: 5.67
Dividend:
  • Annual Dividend: $0.52
  • Dividend Yield: 0.6%
Profitability:
  • EBIDTA: $317.9 million
  • Net Margins: 11.42%
  • Return on Equity: 14.02%
  • Return on Assets: 9.32%
Debt:
  • Debt-to-Equity Ratio: 0.16%
  • Current Ratio: 2.48%
  • Quick Ratio: 1.75%
Misc:
  • Average Volume: 375,528 shs.
  • Beta: 1.13
  • Short Ratio: 4.24
 

Frequently Asked Questions for West Pharmaceutical Services (NYSE:WST)

What is West Pharmaceutical Services' stock symbol?

West Pharmaceutical Services trades on the New York Stock Exchange (NYSE) under the ticker symbol "WST."

How often does West Pharmaceutical Services pay dividends? What is the dividend yield for West Pharmaceutical Services?

West Pharmaceutical Services declared a quarterly dividend on Thursday, July 20th. Investors of record on Wednesday, October 18th will be given a dividend of $0.14 per share on Wednesday, November 1st. This represents a $0.56 dividend on an annualized basis and a dividend yield of 0.59%. The ex-dividend date is Tuesday, October 17th. This is a boost from West Pharmaceutical Services's previous quarterly dividend of $0.13. View West Pharmaceutical Services' Dividend History.

How were West Pharmaceutical Services' earnings last quarter?

West Pharmaceutical Services, Inc. (NYSE:WST) released its quarterly earnings results on Thursday, July, 27th. The company reported $0.66 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $0.65 by $0.01. The company earned $397.60 million during the quarter, compared to analyst estimates of $406 million. West Pharmaceutical Services had a net margin of 11.42% and a return on equity of 14.02%. The business's revenue was up 2.5% compared to the same quarter last year. During the same period last year, the business posted $0.59 EPS. View West Pharmaceutical Services' Earnings History.

When will West Pharmaceutical Services make its next earnings announcement?

West Pharmaceutical Services is scheduled to release their next quarterly earnings announcement on Wednesday, October, 25th 2017. View Earnings Estimates for West Pharmaceutical Services.

What guidance has West Pharmaceutical Services issued on next quarter's earnings?

West Pharmaceutical Services updated its FY17 earnings guidance on Thursday, July, 27th. The company provided EPS guidance of $2.66-2.73 for the period, compared to the Thomson Reuters consensus estimate of $2.67. The company issued revenue guidance of $1.585-1.6 billion, compared to the consensus revenue estimate of $1.61 billion.

Where is West Pharmaceutical Services' stock going? Where will West Pharmaceutical Services' stock price be in 2017?

3 brokers have issued 12-month target prices for West Pharmaceutical Services' shares. Their predictions range from $72.55 to $115.00. On average, they anticipate West Pharmaceutical Services' stock price to reach $93.78 in the next year. View Analyst Ratings for West Pharmaceutical Services.

Who are some of West Pharmaceutical Services' key competitors?

Who are West Pharmaceutical Services' key executives?

West Pharmaceutical Services' management team includes the folowing people:

  • Eric Mark Green, President, Chief Executive Officer, Director
  • William J. Federici, Chief Financial Officer, Senior Vice President, Treasurer
  • Annette F. Favorite, Chief Human Resource Officer, Senior Vice President
  • George Lloyd Miller J.D., Senior Vice President, General Counsel, Corporate Secretary
  • Karen A. Flynn, Senior Vice President and Chief Commercial Officer
  • David A. Montecalvo, Senior Vice President - Global Operations and Supply Chain
  • Eric Resnick, Chief Technology Officer, Vice President
  • Daniel Malone, Vice President, Corporate Controller
  • Michael A. Anderson, Vice President, Treasurer
  • Patrick J. Zenner, Non-Executive Independent Chairman of the Board

Who owns West Pharmaceutical Services stock?

West Pharmaceutical Services' stock is owned by a number of of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (8.86%), BlackRock Inc. (8.40%), Franklin Resources Inc. (5.31%), Neuberger Berman Group LLC (5.06%), State Street Corp (3.39%) and JPMorgan Chase & Co. (2.72%). Company insiders that own West Pharmaceutical Services stock include Daniel Malone, Heino Lennartz, John E Paproski, Karen Flynn, Michael A Anderson, Patrick J Zenner, Paula A Johnson, Thomas W Hofmann, Warwick Bedwell and William J Federici. View Institutional Ownership Trends for West Pharmaceutical Services.

Who sold West Pharmaceutical Services stock? Who is selling West Pharmaceutical Services stock?

West Pharmaceutical Services' stock was sold by a variety of institutional investors in the last quarter, including Victory Capital Management Inc., Eagle Asset Management Inc., Kennedy Capital Management Inc., Neuberger Berman Group LLC, Alliancebernstein L.P., First Trust Advisors LP, Bamco Inc. NY and Hermes Investment Management Ltd.. Company insiders that have sold West Pharmaceutical Services stock in the last year include Daniel Malone, Paula A Johnson and William J Federici. View Insider Buying and Selling for West Pharmaceutical Services.

Who bought West Pharmaceutical Services stock? Who is buying West Pharmaceutical Services stock?

West Pharmaceutical Services' stock was purchased by a variety of institutional investors in the last quarter, including Riverbridge Partners LLC, BlackRock Inc., Koch Industries Inc., Renaissance Technologies LLC, FMR LLC, Prudential Financial Inc., AMI Asset Management Corp and Janus Henderson Group PLC. View Insider Buying and Selling for West Pharmaceutical Services.

How do I buy West Pharmaceutical Services stock?

Shares of West Pharmaceutical Services can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is West Pharmaceutical Services' stock price today?

One share of West Pharmaceutical Services stock can currently be purchased for approximately $95.21.


MarketBeat Community Rating for West Pharmaceutical Services (NYSE WST)
Community Ranking:  1.6 out of 5 (star)
Outperform Votes:  80 (Vote Outperform)
Underperform Votes:  174 (Vote Underperform)
Total Votes:  254
MarketBeat's community ratings are surveys of what our community members think about West Pharmaceutical Services and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for West Pharmaceutical Services (NYSE:WST) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 3 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $93.78 (1.51% downside)

Analysts' Ratings History for West Pharmaceutical Services (NYSE:WST)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
9/15/2017Jefferies Group LLCUpgradeHold -> Buy$96.00 -> $115.00HighView Rating Details
12/23/2016Janney Montgomery ScottReiterated RatingBuyN/AView Rating Details
10/28/2016Wells Fargo & CompanyUpgradeMarket Perform -> OutperformN/AView Rating Details
(Data available from 9/24/2015 forward)

Earnings

Earnings History for West Pharmaceutical Services (NYSE:WST)
Earnings by Quarter for West Pharmaceutical Services (NYSE:WST)
Earnings History by Quarter for West Pharmaceutical Services (NYSE WST)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/25/2017$0.61N/AView Earnings Details
7/27/2017Q2 2017$0.65$0.66$406.00 million$397.60 millionViewN/AView Earnings Details
4/27/2017Q1 2017$0.55$0.81$380.42 million$387.70 millionViewN/AView Earnings Details
2/16/2017Q416$0.56$0.54$387.31 million$382.30 millionViewListenView Earnings Details
10/27/2016Q316$0.53$0.53$371.76 million$376.70 millionViewListenView Earnings Details
7/28/2016Q216$0.56$0.59$384.58 million$388.00 millionViewListenView Earnings Details
4/28/2016Q116$0.51$0.53$355.86 million$362.10 millionViewListenView Earnings Details
2/18/2016Q415$0.47$0.47$364.76 million$359.70 millionViewListenView Earnings Details
10/29/2015Q315$0.43$0.44$355.90 million$344.50 millionViewListenView Earnings Details
7/30/2015Q215$0.45$0.47$356.33 million$359.70 millionViewListenView Earnings Details
4/30/2015Q115$0.40$0.45$346.64 million$335.90 millionViewListenView Earnings Details
2/19/2015Q414$0.46$0.45$348.33 million$349.80 millionViewListenView Earnings Details
10/30/2014Q314$0.43$0.44$356.08 million$355.90 millionViewListenView Earnings Details
7/31/2014Q214$0.47$0.52$368.60 million$368.90 millionViewN/AView Earnings Details
5/1/2014Q114$0.41$0.38$340.90 million$346.80 millionViewListenView Earnings Details
2/20/2014Q413$0.38$0.38$348.70 million$342.70 millionViewListenView Earnings Details
10/31/2013Q3 13$0.36$0.39$333.25 million$341.80 millionViewListenView Earnings Details
8/1/2013Q2 2013$0.82$0.86$349.85 million$344.50 millionViewListenView Earnings Details
5/2/2013Q1 2013$0.86$0.87$344.20 million$339.40 millionViewListenView Earnings Details
2/21/2013Q4 2012$0.56$0.61$318.75 million$321.50 millionViewListenView Earnings Details
11/1/2012Q312$0.50$0.52$306.91 million$303.80 millionViewN/AView Earnings Details
8/2/2012$0.69$0.79ViewN/AView Earnings Details
4/26/2012$0.65$0.83ViewN/AView Earnings Details
2/16/2012$0.55$0.59ViewN/AView Earnings Details
11/1/2011$0.54$0.53ViewN/AView Earnings Details
7/28/2011$0.68$0.62ViewN/AView Earnings Details
4/28/2011$0.62$0.60ViewN/AView Earnings Details
2/17/2011$0.46$0.42ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for West Pharmaceutical Services (NYSE:WST)
2017 EPS Consensus Estimate: $2.34
2018 EPS Consensus Estimate: $2.98
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20171$0.55$0.55$0.55
Q2 20171$0.59$0.59$0.59
Q3 20171$0.54$0.54$0.54
Q4 20171$0.66$0.66$0.66
Q1 20181$0.83$0.83$0.83
Q2 20181$0.81$0.81$0.81
Q3 20181$0.63$0.63$0.63
Q4 20181$0.71$0.71$0.71
(Data provided by Zacks Investment Research)

Dividends

Current Dividend Information for West Pharmaceutical Services (NYSE:WST)
Next Dividend:11/1/2017
Annual Dividend:$0.52
Dividend Yield:0.55%
Dividend Growth:8.40% (3 Year Average)
Payout Ratio:22.22% (Trailing 12 Months of Earnings)
19.40% (Based on This Year's Estimates)
17.93% (Based on Next Year's Estimates)
Track Record:24 Years of Consecutive Dividend Growth
Dividend Payments by Quarter for West Pharmaceutical Services (NYSE:WST)

Dividend History by Quarter for West Pharmaceutical Services (NYSE WST)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/20/2017Quarterly$0.140.6%10/17/201710/18/201711/1/2017
5/16/2017quarterly$0.130.54%7/17/20177/19/20178/2/2017
2/16/2017Quarterly$0.134/17/20174/19/20175/3/2017
12/14/2016quarterly$0.130.61%1/13/20171/18/20172/1/2017
9/12/2016quarterly$0.1310/17/201610/19/201611/2/2016
7/6/2016Quarterly$0.127/18/20167/20/20168/3/2016
3/4/2016Quarterly$0.124/18/20164/20/20165/4/2016
12/17/2015Quarterly$0.121/15/20161/20/20162/3/2016
7/15/2015quarterly$0.120.79%10/19/201510/21/201511/4/2015
7/2/2015quarterly$0.110.76%7/20/20157/22/20158/5/2015
2/20/2015quarterly$0.110.82%4/20/20154/22/20155/6/2015
12/22/2014quarterly$0.110.81%1/16/20151/21/20152/4/2015
7/16/2014quarterly$0.1110/20/201410/22/201411/5/2014
7/16/2014quarterly$0.111.11%10/15/201410/19/201411/3/2014
5/8/2014quarterly$0.100.94%7/21/20147/23/20148/6/2014
2/20/2014quarterly$0.100.83%4/21/20144/23/20145/7/2014
12/19/2013quarterly$0.100.81%1/17/20141/22/20142/5/2014
8/1/2013quarterly$0.2010/23/201311/6/2013
5/10/2013quarterly$0.191.16%7/22/20137/24/20138/7/2013
3/15/2013quarterly$0.191.21%4/15/20134/17/20135/1/2013
12/27/2012quarterly$0.191.4%1/18/20131/23/20132/6/2013
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for West Pharmaceutical Services (NYSE:WST)
Insider Ownership Percentage: 1.90%
Institutional Ownership Percentage: 90.57%
Insider Trades by Quarter for West Pharmaceutical Services (NYSE:WST)
Institutional Ownership by Quarter for West Pharmaceutical Services (NYSE:WST)
Insider Trades by Quarter for West Pharmaceutical Services (NYSE:WST)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/18/2017William J. FedericiCFOSell54,996$95.45$5,249,368.20View SEC Filing  
5/2/2017Daniel MaloneVPSell4,124$93.31$384,810.44View SEC Filing  
12/8/2016Patrick J. ZennerDirectorBuy332$84.53$28,063.96View SEC Filing  
10/31/2016Paula A. JohnsonDirectorSell2,466$75.87$187,095.42View SEC Filing  
9/6/2016Karen FlynnSVPSell14,581$83.28$1,214,305.68View SEC Filing  
8/23/2016Paula A JohnsonDirectorSell3,042$81.55$248,075.10View SEC Filing  
6/2/2016Daniel MaloneVPSell3,950$74.95$296,052.50View SEC Filing  
5/25/2016Thomas W HofmannDirectorSell2,466$73.57$181,423.62View SEC Filing  
3/1/2016Michael A AndersonVPSell16,414$63.58$1,043,602.12View SEC Filing  
2/29/2016Thomas W HofmannDirectorSell3,042$62.70$190,733.40View SEC Filing  
2/25/2016Heino LennartzInsiderSell5,680$62.47$354,829.60View SEC Filing  
2/24/2016Heino LennartzInsiderSell19,658$59.45$1,168,668.10View SEC Filing  
2/23/2016Paula A. JohnsonDirectorSell7,800$59.39$463,242.00View SEC Filing  
2/22/2016Warwick BedwellInsiderSell16,042$59.52$954,819.84View SEC Filing  
11/25/2015John E. PaproskiinsiderSell17,560$63.41$1,113,479.60View SEC Filing  
11/12/2015Heino LennartzInsiderSell3,500$61.87$216,545.00View SEC Filing  
11/6/2015Michael A AndersonVPSell3,000$62.18$186,540.00View SEC Filing  
11/5/2015Michael A. AndersonVPSell10,000$61.98$619,800.00View SEC Filing  
11/4/2015Daniel MaloneVPSell4,456$61.65$274,712.40View SEC Filing  
8/17/2015William J FedericiCFOSell52,678$59.72$3,145,930.16View SEC Filing  
5/28/2015Heino LennartzInsiderSell9,584$55.00$527,120.00View SEC Filing  
5/22/2015Karen FlynnInsiderSell3,091$55.24$170,746.84View SEC Filing  
5/21/2015Eric Mark GreenCEOBuy18,300$54.89$1,004,487.00View SEC Filing  
5/18/2015Karen FlynnInsiderSell1,909$55.00$104,995.00View SEC Filing  
5/15/2015Donald E Morel JrCEOSell20,000$54.29$1,085,800.00View SEC Filing  
2/27/2015Richard D LuzziVPSell10,000$54.85$548,500.00View SEC Filing  
2/26/2015Michael A AndersonVPSell4,682$54.93$257,182.26View SEC Filing  
2/25/2015Heino LennartzInsiderSell3,617$54.82$198,283.94View SEC Filing  
2/24/2015John E PaproskiInsiderSell9,282$52.87$490,739.34View SEC Filing  
2/23/2015Heino LennartzInsiderSell21,040$53.40$1,123,536.00View SEC Filing  
2/23/2015Patrick J ZennerDirectorSell12,800$53.69$687,232.00View SEC Filing  
11/26/2014Richard D LuzziVPSell8,000$52.11$416,880.00View SEC Filing  
11/21/2014William J FedericiCFOSell3,000$51.22$153,660.00View SEC Filing  
11/20/2014Donald E Morel JrCEOSell20,000$51.30$1,026,000.00View SEC Filing  
11/13/2014John R GaileyVPSell28,000$52.37$1,466,360.00View SEC Filing  
11/11/2014Michael A AndersonVPSell4,600$51.73$237,958.00View SEC Filing  
11/10/2014Warwick BedwellInsiderSell6,306$49.95$314,984.70View SEC Filing  
8/21/2014Richard D LuzziVPSell10,000$44.07$440,700.00View SEC Filing  
8/20/2014John R GaileyVPSell20,000$43.96$879,200.00View SEC Filing  
8/19/2014Michael A AndersonVPSell9,800$43.41$425,418.00View SEC Filing  
8/18/2014William J FedericiCFOSell38,366$42.56$1,632,856.96View SEC Filing  
8/13/2014Heino LennartzInsiderSell7,555$39.65$299,555.75View SEC Filing  
8/11/2014Heino LennartzInsiderSell11,445$40.00$457,800.00View SEC Filing  
8/7/2014John E PaproskiInsiderSell14,000$40.44$566,160.00View SEC Filing  
5/30/2014Richard D LuzziVPSell22,828$42.17$962,656.76View SEC Filing  
5/29/2014Heino LennartzInsiderSell2,000$43.00$86,000.00View SEC Filing  
2/28/2014Heino LennartzInsiderSell16,044$45.84$735,456.96View SEC Filing  
2/26/2014Patrick J ZennerDirectorSell12,800$46.12$590,336.00View SEC Filing  
2/24/2014Warwick BedwellInsiderSell24,606$47.49$1,168,538.94View SEC Filing  
11/26/2013Donald E Morel JrCEOSell35,000$48.60$1,701,000.00View SEC Filing  
11/22/2013William J FedericiCFOSell36,000$48.34$1,740,240.00View SEC Filing  
11/19/2013Karen FlynnInsiderSell5,500$47.75$262,625.00View SEC Filing  
11/8/2013Michael A AndersonVPSell9,200$46.80$430,560.00View SEC Filing  
11/7/2013Heino LennartzInsiderSell5,102$46.70$238,263.40View SEC Filing  
11/6/2013Michael A AndersonVPSell6,000$46.53$279,180.00View SEC Filing  
11/5/2013John R GaileyVPSell6,000$46.83$280,980.00View SEC Filing  
11/5/2013Warwick BedwellInsiderSell6,304$46.84$295,279.36View SEC Filing  
11/4/2013Richard D LuzziVPSell38,708$46.99$1,818,888.92View SEC Filing  
8/30/2013Donald E Morel JrCEOSell10,000$74.46$744,600.00View SEC Filing  
8/27/2013John R GaileyVPSell13,749$76.77$1,055,510.73View SEC Filing  
8/22/2013L Robert JohnsonDirectorSell1,883$76.81$144,633.23View SEC Filing  
8/14/2013John E PaproskiInsiderSell6,011$79.08$475,349.88View SEC Filing  
8/12/2013Anthony WeltersDirectorSell19,200$78.43$1,505,856.00View SEC Filing  
8/8/2013Michael A AndersonVPSell4,300$78.00$335,400.00View SEC Filing  
5/31/2013Michael A AndersonVPSell4,000$68.94$275,760.00View SEC Filing  
5/28/2013Donald E Morel JrCEOSell10,000$67.87$678,700.00View SEC Filing  
5/24/2013L Robert JohnsonDirectorSell1,700$67.47$114,699.00View SEC Filing  
5/20/2013John R GaileyVPSell9,282$68.54$636,188.28View SEC Filing  
5/17/2013L Robert JohnsonDirectorSell4,000$67.80$271,200.00View SEC Filing  
5/8/2013L Robert JohnsonDirectorSell6,400$64.49$412,736.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for West Pharmaceutical Services (NYSE:WST)
Latest Headlines for West Pharmaceutical Services (NYSE:WST)
Source:
DateHeadline
americanbankingnews.com logoJefferies Group Equities Analysts Raise Earnings Estimates for West Pharmaceutical Services, Inc. (WST)
www.americanbankingnews.com - September 18 at 4:50 AM
americanbankingnews.com logoZimmer Biomet Holdings (ZBH) and West Pharmaceutical Services (WST) Head-To-Head Review
www.americanbankingnews.com - September 17 at 8:26 AM
americanbankingnews.com logoWest Pharmaceutical Services, Inc. (WST) Upgraded by Jefferies Group LLC to "Buy"
www.americanbankingnews.com - September 16 at 12:26 AM
americanbankingnews.com logo Analysts Set $102.75 Target Price for West Pharmaceutical Services, Inc. (WST)
www.americanbankingnews.com - September 15 at 10:36 PM
americanbankingnews.com logo$0.53 EPS Expected for West Pharmaceutical Services, Inc. (WST) This Quarter
www.americanbankingnews.com - September 15 at 6:24 PM
247wallst.com logoFriday's Top Analyst Upgrades and Downgrades: AbbVie, Bristol-Myers, Eli Lilly ...
247wallst.com - September 15 at 11:34 AM
finance.yahoo.com logoWest Pharmaceutical Services, Inc. – Value Analysis (NYSE:WST) : September 13, 2017
finance.yahoo.com - September 13 at 1:26 AM
finance.yahoo.com logoWest Pharmaceutical Services, Inc. breached its 50 day moving average in a Bullish Manner : WST-US : September 11, 2017
finance.yahoo.com - September 12 at 12:20 PM
americanbankingnews.com logo West Pharmaceutical Services, Inc. (WST) Given Consensus Rating of "Buy" by Brokerages
www.americanbankingnews.com - September 9 at 10:24 AM
nasdaq.com logoWest Pharmaceutical Services (WST) Shares Cross Above 200 DMA
www.nasdaq.com - September 1 at 9:05 PM
finance.yahoo.com logoWest Pharmaceutical Services, Inc. : WST-US: Dividend Analysis : July 19th, 2017 (record date) : By the numbers : August 24, 2017
finance.yahoo.com - August 25 at 12:46 PM
finance.yahoo.com logoWest Announces Fall Investor Conference Schedule
finance.yahoo.com - August 25 at 12:46 PM
americanbankingnews.com logo Brokerages Set $104.00 Target Price for West Pharmaceutical Services, Inc. (WST)
www.americanbankingnews.com - August 25 at 8:54 AM
finance.yahoo.com logoETFs with exposure to West Pharmaceutical Services, Inc. : August 16, 2017
finance.yahoo.com - August 17 at 9:25 AM
finance.yahoo.com logoSee what the IHS Markit Score report has to say about West Pharmaceutical Services Inc.
finance.yahoo.com - August 12 at 8:54 AM
americanbankingnews.com logo Analysts Expect West Pharmaceutical Services, Inc. (NYSE:WST) Will Post Earnings of $0.53 Per Share
www.americanbankingnews.com - August 9 at 8:24 PM
americanbankingnews.com logoAnalyzing West Pharmaceutical Services (NYSE:WST) & OraSure Technologies (OSUR)
www.americanbankingnews.com - August 6 at 12:28 PM
americanbankingnews.com logoBidaskClub Downgrades West Pharmaceutical Services, Inc. (NYSE:WST) to Strong Sell
www.americanbankingnews.com - August 3 at 1:12 PM
finance.yahoo.com logoWest Pharmaceutical Services, Inc. :WST-US: Earnings Analysis: Q2, 2017 By the Numbers : August 2, 2017
finance.yahoo.com - August 3 at 8:57 AM
americanbankingnews.com logoWest Pharmaceutical Services, Inc. to Post Q3 2017 Earnings of $0.54 Per Share, Jefferies Group Forecasts (NYSE:WST)
www.americanbankingnews.com - July 31 at 7:03 AM
finance.yahoo.com logoEdited Transcript of WST earnings conference call or presentation 27-Jul-17 1:00pm GMT
finance.yahoo.com - July 29 at 8:49 AM
nasdaq.com logoWest Pharmaceutical Services Becomes Oversold (WST)
www.nasdaq.com - July 28 at 10:04 AM
americanbankingnews.com logoWest Pharmaceutical Services, Inc. (WST) Downgraded by BidaskClub
www.americanbankingnews.com - July 27 at 5:14 PM
americanbankingnews.com logoWest Pharmaceutical Services, Inc. (WST) Issues Earnings Results
www.americanbankingnews.com - July 27 at 1:47 PM
americanbankingnews.com logoWest Pharmaceutical Services, Inc. (NYSE:WST) Releases FY17 Earnings Guidance
www.americanbankingnews.com - July 27 at 11:51 AM
finance.yahoo.com logoWest Announces Second-Quarter 2017 Results
finance.yahoo.com - July 27 at 9:38 AM
finance.yahoo.com logoWest Pharmaceutical misses Street 2Q forecasts
finance.yahoo.com - July 27 at 9:38 AM
americanbankingnews.com logoZacks: West Pharmaceutical Services, Inc. (WST) Given $107.50 Average Target Price by Analysts
www.americanbankingnews.com - July 25 at 9:59 AM
americanbankingnews.com logoWest Pharmaceutical Services, Inc. (WST) Announces Dividend Increase - $0.14 Per Share
www.americanbankingnews.com - July 21 at 12:20 PM
finanznachrichten.de logoGlobal Pharmaceutical Packaging Market 2014 - 2025
www.finanznachrichten.de - July 21 at 8:50 AM
americanbankingnews.com logoZacks: Brokerages Expect West Pharmaceutical Services, Inc. (NYSE:WST) to Announce $0.65 EPS
www.americanbankingnews.com - July 20 at 2:32 PM
finance.yahoo.com logoWest Announces Increase to Quarterly Dividend
finance.yahoo.com - July 20 at 9:16 AM
americanbankingnews.com logoZacks Investment Research Lowers West Pharmaceutical Services, Inc. (NYSE:WST) to Sell
www.americanbankingnews.com - July 19 at 11:18 AM
americanbankingnews.com logoWest Pharmaceutical Services, Inc. (NYSE:WST) Set to Announce Quarterly Earnings on Wednesday
www.americanbankingnews.com - July 19 at 8:53 AM
finance.yahoo.com logoGerresheimer licenses syringe safety solution from West
finance.yahoo.com - July 17 at 12:31 PM
nasdaq.com logoWest Pharmaceutical Services, Inc. (WST) Ex-Dividend Date Scheduled for July ...
www.nasdaq.com - July 15 at 9:44 AM
finance.yahoo.com logoDividend Coverage: This Healthcare Company has Raised Dividend for 24 Consecutive Years; Will Trade Ex-Dividend on July 17, 2017
finance.yahoo.com - July 14 at 10:04 AM
americanbankingnews.com logoBidaskClub Lowers West Pharmaceutical Services, Inc. (WST) to Hold
www.americanbankingnews.com - July 5 at 3:18 PM
americanbankingnews.com logoWest Pharmaceutical Services, Inc. (NYSE:WST) Downgraded by Zacks Investment Research
www.americanbankingnews.com - July 4 at 11:42 AM
finance.yahoo.com logoWest Pharmaceutical Services, Inc. – Value Analysis (NYSE:WST) : July 3, 2017
finance.yahoo.com - July 4 at 8:53 AM
americanbankingnews.com logoJefferies Group Equities Analysts Decrease Earnings Estimates for West Pharmaceutical Services, Inc. (NYSE:WST)
www.americanbankingnews.com - July 3 at 7:59 AM
finance.yahoo.com logoWest Pharmaceutical Services, Inc. breached its 50 day moving average in a Bearish Manner : WST-US : June 30, 2017
finance.yahoo.com - July 1 at 9:10 AM
americanbankingnews.com logoWest Pharmaceutical Services, Inc. (WST) to Post Q4 2017 Earnings of $0.66 Per Share, Jefferies Group Forecasts
www.americanbankingnews.com - June 30 at 10:10 AM
americanbankingnews.com logoHead-To-Head Review: West Pharmaceutical Services (WST) vs. Covidien (COV)
www.americanbankingnews.com - June 28 at 8:38 PM
americanbankingnews.com logoWest Pharmaceutical Services, Inc. (WST) Expected to Announce Quarterly Sales of $405.33 Million
www.americanbankingnews.com - June 28 at 11:56 AM
americanbankingnews.com logo Analysts Expect West Pharmaceutical Services, Inc. (WST) to Announce $0.65 Earnings Per Share
www.americanbankingnews.com - June 26 at 12:32 PM
americanbankingnews.com logoWest Pharmaceutical Services, Inc. (WST) Upgraded at Zacks Investment Research
www.americanbankingnews.com - June 23 at 7:56 AM
americanbankingnews.com logoWest Pharmaceutical Services, Inc. (WST) Cut to Hold at Zacks Investment Research
www.americanbankingnews.com - June 22 at 9:52 AM
americanbankingnews.com logoWest Pharmaceutical Services, Inc. (WST) Cut to "Hold" at Zacks Investment Research
www.americanbankingnews.com - June 16 at 9:26 AM
americanbankingnews.com logo West Pharmaceutical Services, Inc. (WST) Given Consensus Recommendation of "Buy" by Analysts
www.americanbankingnews.com - June 13 at 8:32 PM

Social

Chart

West Pharmaceutical Services (WST) Chart for Sunday, September, 24, 2017

This page was last updated on 9/24/2017 by MarketBeat.com Staff